Please assess the completion status of the following clinical trial:

Trial Title: Polyprenols (Ropren) in Acute Coronary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute coronary syndrome~* Informed consent received~Exclusion Criteria:~* Patient's incapacity to take accurately drops by oneself~* Cardiogenic shock

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo Group (Type: PLACEBO_COMPARATOR): Oil: 8 drops 3 times per day for 3 weeks, then 5 drops 3 times per day for 5 weeks
- Polyprenol Group (Type: EXPERIMENTAL): Polyprenols (ROPREN): 8 drops 3 times per day for 3 weeks, then 5 drops 3 times per day for 5 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).